Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

Development of a new radiotracer (11C-MPTB) for imaging of metabotropic glutamate receptor subtype 5 in brain

Ming-Rong Zhang, Yoko Shimoda, Tomoteru Yamasaki, Masayuki Fujinaga, Joji Yui, Akiko Hatori, Yiding Zhang and Kazunori Kawamura
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1037;
Ming-Rong Zhang
1National Institute of Radiological Sciences Chiba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoko Shimoda
1National Institute of Radiological Sciences Chiba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomoteru Yamasaki
1National Institute of Radiological Sciences Chiba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masayuki Fujinaga
1National Institute of Radiological Sciences Chiba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joji Yui
1National Institute of Radiological Sciences Chiba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akiko Hatori
1National Institute of Radiological Sciences Chiba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yiding Zhang
1National Institute of Radiological Sciences Chiba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazunori Kawamura
1National Institute of Radiological Sciences Chiba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1037

Objectives Metabotropic glutamate receptor 5 (mGluR5) is characterized as a G protein coupled receptor and is known as one of regulators for excitatory neurotransmission, which is involved in central nervous system (CNS) disorders, such as fragile X syndrome, Parkinson’s disease, and depression. Therefore, mGluR5 is an important target for development of new pharmaceuticals against these CNS disorders. The most widely used PET radiotracer for mGluR5 was (E)-11C-ABP688 containing alkyne moiety. However, some test-retest PET studies with this radiotracer indicated low reliability for quantification of mGluR5 density. Here, we describe the synthesis of a new radiotracer 11C-MPTB not containing alkyne moiety and evaluation for PET imaging of mGluR5 in brain.

Methods MPTB and its arylstannyl precursor for radiolabeling were synthesized using commercially available compounds. 11C-MPTB was synthesized via C-11C-methylation of the precursor with 11C-methyl iodide. In vitro binding of 11C-MPTB to mGluR5 was characterized by homogenate assay and autoradiography using rat brain. Further, in vivo brain regional distribution and test-retest reliability of 11C-MPTB were determined by small-animal PET assessments.

Results 11C-MPTB was synthesized with 25 ± 14% (n = 11) radiochemical yield at 32 min after end of bombardment and 52-190 GBq/µmol specific activity at the end of synthesis. MPTB showed high in vitro binding affinity (Ki = 9.4 nM) for mGluR5. In vitro autoradiography with 11C-MPTB exhibited heterogeneous distribution pattern of radioactivity in the rat brain sections, which corresponded with the biological localization of mGluR5. These radioactive accumulations were totally diminished by co-incubation with mGluR5-selective antagonist MPEP. In the PET study, the time-activity curves of 11C-MPTB immediately reached maximum levels after the injection and then quickly decreased. The uptake ratio of each region against cerebellum, a reference region for mGluR5, under the equilibrium state was 3.0 ± 0.1 in the striatum, the richest brain region with mGluR5. By treatment with MPEP, the ratio decreased to 1.3. The parametric PET images scaled with binding potential visualized regional differences in specific binding to mGluR5, indicating that PET with 11C-MPTB could provide significant signal for mGluR5 in brain regions. Moreover, test-retest PET studies with this tracer exhibited high reliability for quantification of mGluR5 density.

Conclusions 11C-MPTB is a useful PET radiotracer for the imaging and quantitative analysis of mGluR5 in brain and may merit further evaluation in humans.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Development of a new radiotracer (11C-MPTB) for imaging of metabotropic glutamate receptor subtype 5 in brain
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Development of a new radiotracer (11C-MPTB) for imaging of metabotropic glutamate receptor subtype 5 in brain
Ming-Rong Zhang, Yoko Shimoda, Tomoteru Yamasaki, Masayuki Fujinaga, Joji Yui, Akiko Hatori, Yiding Zhang, Kazunori Kawamura
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1037;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Development of a new radiotracer (11C-MPTB) for imaging of metabotropic glutamate receptor subtype 5 in brain
Ming-Rong Zhang, Yoko Shimoda, Tomoteru Yamasaki, Masayuki Fujinaga, Joji Yui, Akiko Hatori, Yiding Zhang, Kazunori Kawamura
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1037;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

SPECIAL MTA: Preclinical Probes for Neuroimaging Posters

  • Synthesis of 1-(2-{2-[4-Fluoro-2-(4-[18F]fluorobenzoyl)phenyl]vinyloxy}ethyl)nipecotic Acid for PET imaging of GAT-1
  • RAGE-specific probe 18F -FPS-ZM1 may be a promising biomarker for early detection of Diabetes with Alzheimer's disease
Show more SPECIAL MTA: Preclinical Probes for Neuroimaging Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire